bB Medicated Pain Relieving Oil

Manufacturer
BB BIOCHEM LABORATORIES, INC.
Effective date
2014-11-01
Label type
HUMAN OTC DRUG LABEL
Version
8
Source
full-release
Hydrated at
2026-05-31 22:41:16

Label at a glance#

ProductbB Medicated Pain Relieving Oil
Active ingredientCAMPHOR (SYNTHETIC), LEVOMENTHOL, METHYL SALICYLATE, EUCALYPTUS OIL, CAPSAICIN, CAMPHOR (NATURAL)
Label structure17 sections

Indications and uses

Apply on Skin only ; for temporary relief of minor aches & pains of muscles & joints associated with sports and/or aging symptoms: ■ Simple backache ■ arthritis ■ strains ■ bruises ■ sprains

Dosage and administration

If prone to allergic reaction from aspirin or salicylates, consult a doctor before use Adults and children12 years of age and over : ■ clean and dry affected area. ■ apply to affected area not more than 2 times a day. Children under 12 years of age : ■ consult a doctor

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Capsaicin natural extract 0.25 % as capsaicin

Camphor 3 %

Menthol 12 %

Methyl Salicylate 15 %

Eucalyptus Oil 15 %

Purpose

OTC - PURPOSE SECTION

Capsaicin natural extract ........................................... .Topical Analgesic

Camphor …………………………………………….........Topical Analgesic

Menthol ....................................................................... Topical Analgesic

Methyl Salicylate ..........................................................Topical Analgesic

Eucalyptus Oil ..............................................................Topical Analgesic

Uses

INDICATIONS & USAGE SECTION

Apply on Skin only; for temporary relief of minor aches & pains of muscles & joints associated with sports and/or aging symptoms:

■ Simple backache ■ arthritis ■ strains ■ bruises ■ sprains

Warnings

WARNINGS SECTION

Keep out reach of children

If swallowed, get medical help or contact poison control center immediately.

Do not use

■ on wounds or damaged skin.

■ with a heating pad

■ with, or at the same time as, other external analgesic products.

■ if you are allergic to any ingredients of this product.

When using this product:

■ do not use otherwise than as directed.

■ avoid contact with eyes, mucous membranes or rashes.

Stop use and consult a doctor for:

■ rash, itching or excessive skin irritation develops.

■ conditions worsen.

■ symptoms persist for more than7 days.

■ symptoms clear up and occur again within a few days.

If swallowed, get medical help or contact poison control center immediately.

Directions and Allergy alert:

OTC - ASK DOCTOR SECTION

If prone to allergic reaction from aspirin or salicylates, consult a doctor before use

Adults and children12 years of age and over:

■ clean and dry affected area.

■ apply to affected area not more than 2 times a day.

Children under 12 years of age:

■ consult a doctor

Flammable and Safe Handling

SAFE HANDLING WARNING SECTION

  • keep away from fire or flame
  • do not use where ignition sparks happens
  • do not use in a confined space
  • do not incinerate or heat the bottle
  • do not expose bottle to temeprature exceeding 120 degree F (48 degree C)

Do NOT use:

OTC - DO NOT USE SECTION

  • on wounds or damaged skins.
  • with a heating pad.
  • if you are allergic to any ingredients of this product

When using this product:

OTC - WHEN USING SECTION

  • do not use otherwise than directed to.
  • avoid contact with the eyes, mucous membranes or rashes.
  • do not bandage tightly.
  • do not use on open wounds

Stop use and ask a doctor if any of the following happens:

OTC - STOP USE SECTION

  • rash, itching or excessive skin irritation develops
  • conditions worsen
  • symptoms persist for more than 7 days
  • symptoms clear up and return again within a few days

Pregancy or Breast Feeding.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If you are pregnant or breastfeeding, consult with your physician or a healthcare provider before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Warnings

If swallowed, get medical help or contact poison control center immediately.

Children under 12 years of age:

OTC - ASK DOCTOR SECTION

■ consult a doctor

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Purified water, Ethanol, Cetyl alcohol, Polysorbate 80, Sorbitan monolaurate, Isopropyl myristate.

Other Information

OTHER SAFETY INFORMATION

■ Due to its unique formulation, the solution can turn into different levels of white translucent, milky cloudiness at warmer temperatures; This is totally normal. Upon returning to cooler temperatures it should regain its typical transparency state.

■ Avoid storing product in direct sunlight.

■ Protect product from excessive moisture.

Principle Display Panel-Extra Strength-Capsaicin 0.25/100

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC#61079-025-13

bB Medicated Oil Pain Reliever

Extra Strength

0.5 FL. OZ. (13 mL)

bB BioChem Laboratories, Inc.

Distributed by

bB BioChem Laboratories, Inc.

Santa Ana, CA 92705

bB BioChemUSA.com

Extra Strength Capsaicin 0.25/100Extra Strength Capsaicin 0.25/100

Carton-Extra Strenght- Capsaicin 0.25/100Carton-Extra Strenght- Capsaicin 0.25/100

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children12 years of age and over:

  • clean and dry affected area.
  • apply to affected area not more than 2 times a day.

Children under 12 years of age:

  • consult a doctor

Principle Display Panel-Sensitive Strength-Capsaicin 0.14/100

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC#61079-014-13

bB Medicated Oil Pain Reliever

Sensitive Strength-Capsaicin 0.14/100

0.5 FL. OZ. (13 mL)

bB BioChem Laboratories, Inc.

Distributed by

bB BioChemLaboratories, Inc.

Santa Ana, CA 92705

bBBioChemUSA.com

Sensitive Strenght-Capsaicin 0.14/100Sensitive Strenght-Capsaicin 0.14/100

Sensitive Strenght-Capsaicin 0.14/100Sensitive Strenght-Capsaicin 0.14/100

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1598277camphor 3 % / capsaicin 0.25 % / eucalyptus oil 15 % / menthol 12 % / methyl salicylate 15 % Topical OilPSN8
1598277camphor 30 MG/ML / capsaicin 2.5 MG/ML / Eucalyptus oil 150 MG/ML / menthol 120 MG/ML / methyl salicylate 150 MG/ML Topical OilSCD8
1598277camphor 3 % / capsaicin 0.25 % / eucalyptus oil 15 % / menthol 12 % / methyl salicylate 15 % Topical OilSY8

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
473d070d-1c38-488e-b991-c4d1bf45aab8Product name120210201
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408
7792dadb-52b6-46b6-8fdf-80b1171065b5Product name120180810

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
61079-014-13bB Medicated Pain Relieving Oil13 g in 1 BOTTLE, GLASSOIL138
61079-025-13bB Medicated Pain Relieving Oil13 g in 1 BOTTLE, GLASSOIL138

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
61079-014BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.]8Legacy NDC, 1 package rows20150105_07b43c31-a4d2-5c29-e054-00144ff88e88.zip
61079-025BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.]8Legacy NDC, 1 package rows20150105_07b43c31-a4d2-5c29-e054-00144ff88e88.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
CAMPHOR (NATURAL)ACTIVE INGREDIENTN20HL7Q9418
CAMPHOR (SYNTHETIC)ACTIVE INGREDIENT5TJD82A1ET8
CAPSAICINACTIVE INGREDIENTS07O44R1ZM8
EUCALYPTUS OILACTIVE INGREDIENT2R04ONI6628
LEVOMENTHOLACTIVE INGREDIENTBZ1R15MTK78
METHYL SALICYLATEACTIVE INGREDIENTLAV5U5022Y8
CAMPHOR (NATURAL)ACTIVE MOIETYN20HL7Q9418
CAMPHOR (SYNTHETIC)ACTIVE MOIETY5TJD82A1ET8
CAPSAICINACTIVE MOIETYS07O44R1ZM8
EUCALYPTUS OILACTIVE MOIETY2R04ONI6628
LEVOMENTHOLACTIVE MOIETYBZ1R15MTK78
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZ8
ALCOHOLINACTIVE INGREDIENT3K9958V90M8
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCN8
ISOPROPYL MYRISTATEINACTIVE INGREDIENT0RE8K4LNJS8
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8H8
SORBITAN MONOLAURATEINACTIVE INGREDIENT6W9PS8B71J8
WATERINACTIVE INGREDIENT059QF0KO0R8

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
61079-02561079-025-13
61079-01461079-014-13

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 22 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 187 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSOLUTION / INTRAVENOUS900 mgExact identifier — unii candidate
78 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION, SOLUTION / INTRAMUSCULAR1000 mgExact identifier — unii candidate
59 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNSUSPENSION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
20 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSUPPOSITORY / RECTAL72.15 mgExact identifier — unii candidate
78 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / ORAL3563 mgExact identifier — unii candidate
59 equally ranked IID candidates
SORBITAN MONOLAURATESORBITAN MONOLAURATE6W9PS8B71JAEROSOL, FOAM / TOPICAL341 mgExact identifier — unii candidate
12 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, SUSPENSION / INTRAMUSCULAR4 mgExact identifier — unii candidate
78 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNTABLET, FILM COATED / ORALNAExact identifier — unii candidate
20 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HCAPSULE, COATED / ORAL0.04 mgExact identifier — unii candidate
78 equally ranked IID candidates
SORBITAN MONOLAURATESORBITAN MONOLAURATE6W9PS8B71JSUSPENSION / ORAL2.5 mg/5mlExact identifier — unii candidate
12 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, SPRAY / RESPIRATORY (INHALATION)35.75 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MPOWDER, FOR SOLUTION / TOPICAL40 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSSYSTEM / TRANSDERMAL113 mgExact identifier — unii candidate
18 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION, SOLUTION / SUBCUTANEOUS6.1 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, POWDER, FOR SUSPENSION / INTRA-ARTICULAR5 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSPRAY, METERED / NASAL0.1 mg/1mlExact identifier — unii candidate
78 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNAEROSOL, FOAM / RECTAL17 mgExact identifier — unii candidate
20 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNCAPSULE, DELAYED RELEASE / ORAL59 mgExact identifier — unii candidate
20 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION / INTRAVASCULAR100 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSUPPOSITORY / VAGINAL28 mgExact identifier — unii candidate
78 equally ranked IID candidates
SORBITAN MONOLAURATESORBITAN MONOLAURATE6W9PS8B71JCREAM / TOPICAL0.5 %w/wExact identifier — unii candidate
12 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY / NASAL20 mgExact identifier — unii candidate
59 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HDROPS / OPHTHALMIC0.05 %w/wExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HPOWDER / ORAL66 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSOLUTION / ORAL907 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, SOLUTION / INTRAVENOUS1170 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL34 mgExact identifier — unii candidate
78 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSAEROSOL / TOPICAL9.3 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, FOAM / TOPICAL4504 mgExact identifier — unii candidate
59 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, SUSPENSION / SOFT TISSUE4 mgExact identifier — unii candidate
78 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL, METERED / TOPICAL541 mgExact identifier — unii candidate
59 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSOLUTION / AURICULAR (OTIC)0.2 %w/wExact identifier — unii candidate
78 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSUSPENSION / ORAL681 mgExact identifier — unii candidate
59 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HCAPSULE / ORAL418.37 mgExact identifier — unii candidate
78 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY / TRANSDERMAL90 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / INTRAVENOUS400 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCONCENTRATE / ORAL198 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCAPSULE / ORAL882 mgExact identifier — unii candidate
59 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSOIL / TOPICAL213 mgExact identifier — unii candidate
18 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HTABLET, FILM COATED, EXTENDED RELEASE / ORAL8 mgExact identifier — unii candidate
78 equally ranked IID candidates
SORBITAN MONOLAURATESORBITAN MONOLAURATE6W9PS8B71JSPRAY, METERED / NASAL1 mgExact identifier — unii candidate
12 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HCAPSULE, COATED PELLETS / ORAL2 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HCONCENTRATE / INTRAVENOUS4680 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HAEROSOL, FOAM / VAGINAL3 %w/wExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HELIXIR / ORAL2.5 mg/15mlExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HCAPSULE, EXTENDED RELEASE / ORAL10 mgExact identifier — unii candidate
78 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MMOUTHWASH / BUCCAL200 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HEMULSION / TOPICAL34050 mgExact identifier — unii candidate
78 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / RESPIRATORY (INHALATION)5 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNEMULSION / TOPICALNAExact identifier — unii candidate
20 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC0.05 %w/wExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSUSPENSION/ DROPS / OPHTHALMIC1 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, SUSPENSION / SUBCUTANEOUS0.3 %w/vExact identifier — unii candidate
78 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MDROPS / NASAL10 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR1 mgExact identifier — unii candidate
78 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNTABLET / ORALNAExact identifier — unii candidate
20 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION, CONCENTRATE / ORAL150.68 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNSUSPENSION / TOPICAL2.01 %w/wExact identifier — unii candidate
20 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSUSPENSION / RESPIRATORY (INHALATION)1 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HGEL / TOPICAL12 mgExact identifier — unii candidate
78 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
0bc4e3b7-24a6-435a-e054-00144ff88e8807b43c31-a4d2-5c29-e054-00144ff88e882014-11-01WarningsExact identifier
spl id: 0bc4e3b7-24a6-435a-e054-00144ff88e88
spl set id: 07b43c31-a4d2-5c29-e054-00144ff88e88

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.